Cancer drug development is known to be too slow, costly and fraught with failure. Now the U.S. Food and Drug Administration is issuing recommendations for breast cancer trials that would substantially accelerate patient access ...
Jun 4, 2012
0
0
(HealthDay) -- For young men, increasing physical activity over a five-year period is associated with improvements in bone mineral content (BMC) and bone mineral density (BMD), according to a study published in the May issue ...
May 21, 2012
0
0
Compounds in blueberries might turn out to have a powerful effect on formation of strong, healthy bones, if results from studies with laboratory rats turn out to hold true for humans.
Jun 21, 2011
0
0
Swiss drug maker Novartis says it will cooperate with California-based biotech giant Amgen to develop and sell neuroscience treatments for illnesses and ailments like Alzheimer's disease and migraine headaches.
Sep 2, 2015
0
12
In advance of this month's World Health Assembly and the G7 summit in June, world leaders should consider the establishment of a global biomedical research and development fund and a mechanism to address the dearth in innovation ...
May 11, 2015
0
6
Hundreds of British drugmaker GlaxoSmithKline's 17,000 U.S.-based employees will lose their jobs by the end of next year under the pharmaceutical industry's latest restructuring.
Dec 4, 2014
0
0
The recent renaming of the Telethon Kids Institute has brought more change than just the name—it's bringing a new approach to health research.
Apr 10, 2014
0
0
British drugmaker GlaxoSmithKline said Wednesday that third-quarter net profits fell 18.5 percent from a year earlier to £1.12 billion ($1.80 billion, 1.39 billion euros), hit by weak conditions in Europe.
Nov 1, 2012
0
0
(AP)—A Japanese pharmaceutical company is acquiring LigoCyte Pharmaceuticals in a $60 million deal to expand its vaccine division, Takeda Pharmaceutical Co. announced.
Oct 5, 2012
0
0
(AP)—Valeant Pharmaceuticals International Inc. has agreed to buy dermatology products maker Medicis Pharmaceutical Corp. for about $2.6 billion in cash in a deal to strengthen its position in skin treatments and care.
Sep 3, 2012
0
0
